Sandbox Reserved 994
From Proteopedia
(Difference between revisions)
| Line 9: | Line 9: | ||
== Bacterial Resistance == | == Bacterial Resistance == | ||
| - | Since the discovery of penicillin by Alexander Flemming in 1928, antibiotics have revolutionized the medical world. Penicillin is known as a β-lactam antibiotic which is characterized by a four-membered β-lactam ring (a cyclic amide). There are four classes of β-lactam antibiotics: monobactams, which are the simplest class of β-lactam, and aren’t fused to any rings, penicillins, which have a thiazole ring fused to the β-lactam, cephalosporins which contain a thiazine ring, and lastly, carbapenems, which are fused with a pyrrole ring and are considered a last line of defense. <ref>doi:10.3390/antibiotics3020128#sthash.iyPihLj1.dpuf</ref> β-lactam antibiotics are the most widely used class of antibiotics because they successfully fight most bacterial infections by inhibiting cell wall synthesis. Their mechanism of action is through inhibition of the transpeptidase enzymes, located in the bacterial cell membrane. Transpeptidase is often referred to as a penicillin-binding protein (PBP) and is responsible for cross-linking the bacterial cell wall <ref>PMCID: PMC162717</ref>. β-lactams mimic the structure of the usual PBP substrate and therefore disrupt the cross-linking process that is critical to cell wall synthesis. Once the β-lactam ring binds, the PBP is irreversibly inactivated. As a result, the bacterial cell wall is compromised, and the bacteria lyse and die.<ref>Patrick, G. (2005). Antibacterial Agents. An Introduction to Medicinal Chemistry (3rd Ed), pages 388-414 </ref> | + | Since the discovery of penicillin by Alexander Flemming in 1928, antibiotics have revolutionized the medical world. Penicillin is known as a β-lactam antibiotic which is characterized by a four-membered β-lactam ring (a cyclic amide). There are four classes of β-lactam antibiotics: monobactams, which are the simplest class of β-lactam, and aren’t fused to any rings, penicillins, which have a thiazole ring fused to the β-lactam, cephalosporins which contain a thiazine ring, and lastly, carbapenems, which are fused with a pyrrole ring and are considered a last line of defense. <ref>doi:10.3390/antibiotics3020128#sthash.iyPihLj1.dpuf</ref> β-lactam antibiotics are the most widely used class of antibiotics because they successfully fight most bacterial infections by inhibiting cell wall synthesis. Their mechanism of action is through inhibition of the transpeptidase enzymes, located in the bacterial cell membrane. Transpeptidase is often referred to as a penicillin-binding protein (PBP) and is responsible for cross-linking the bacterial cell wall <ref>PMCID: PMC162717</ref>. β-lactams mimic the structure of the usual PBP substrate and therefore disrupt the cross-linking process that is critical to cell wall synthesis. Once the β-lactam ring binds, the PBP is irreversibly inactivated. As a result, the bacterial cell wall is compromised, and the bacteria lyse and die.<ref>Patrick, G. (2005). Antibacterial Agents. An Introduction to Medicinal Chemistry (3rd Ed), pages 388-414. </ref> |
| - | Due to overperscription and misuse of antibiotics, bacteria have been able to develop resistance mechanisms. One of these resistance mechanisms is through the expression of β-lactamases. β-lactamases act by cleaving the β-lactam ring which renders the antibiotic inactive before it has a chance to inhibit the transpeptidase enzymes | + | Due to overperscription and misuse of antibiotics, bacteria have been able to develop resistance mechanisms. One of these resistance mechanisms is through the expression of β-lactamases. β-lactamases act by cleaving the β-lactam ring which renders the antibiotic inactive before it has a chance to inhibit the transpeptidase enzymes.<ref>Neu, Harold. "The Crisis in Antibiotic Resistance." Science (1992) 257, 5073. ProQuest Medical Library: p. 1064-1072.</ref> β-lactamases are grouped into four different classes (A, B, C and D) which all (besides class B) use a serine based mechanism for destruction of β-lactams. Class B β-lactamases use zinc ions for hydrolysis. In 1980, R.P. Ambler described the first two classes of β-lactamases: Class A and B. Class A were expressed by Staphylococcus aureus and class B were expressed by Bacillus cereus. Afterwards, Jaurin and Grundstorm observed class C enzymes which hydrolyze cephalosporins. Class D was distinguished from other serine β-lactamases in the late 1980s, due to having an affinity for oxacillin as its substrate in addition to carbapenems.<ref>doi: 10.1128/AAC.01009-09</ref> Even more concerning is that the class D β-lactamases, or OXAs, are not inhibited by current clinical β-lactamase inhibitors, such as clavulanic acid. OXA-24 poses a high clinical threat due to its lack of an effective inhibitor. |
== CHDLs == | == CHDLs == | ||
| Line 27: | Line 27: | ||
[[Image:Beta-lactamase resized mechanism.png]] | [[Image:Beta-lactamase resized mechanism.png]] | ||
| - | The mechanism of attack involves a catalytic serine residue, a carboxylated lysine, and another active site serine which contributes to proton movement (A). A high energy tetrahedral intermediate (B) is generated and an acyl enzyme intermediate (C) is formed after the cleavage of the four-membered ring. KCX84 activates the deacylating water which completes the reaction leaving a hydrolyzed β-lactam ring and a regenerated β-lactamase | + | The mechanism of attack involves a catalytic serine residue, a carboxylated lysine, and another active site serine which contributes to proton movement (A). A high energy tetrahedral intermediate (B) is generated and an acyl enzyme intermediate (C) is formed after the cleavage of the four-membered ring. KCX84 activates the deacylating water which completes the reaction leaving a hydrolyzed β-lactam ring and a regenerated β-lactamase.<ref>DOI: 10.1021/ar300327a</ref> |
<scene name='69/691536/Closeupdrug/1'>close up</scene><ref>PMID: 10817708</ref> | <scene name='69/691536/Closeupdrug/1'>close up</scene><ref>PMID: 10817708</ref> | ||
Revision as of 20:29, 21 February 2015
| This Sandbox is Reserved from 20/01/2015, through 30/04/2016 for use in the course "CHM 463" taught by Mary Karpen at the Grand Valley State University. This reservation includes Sandbox Reserved 987 through Sandbox Reserved 996. |
To get started:
More help: Help:Editing |
OXA-24 β-lactamase
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Leonard DA, Bonomo RA, Powers RA. Class D beta-lactamases: a reappraisal after five decades. Acc Chem Res. 2013 Nov 19;46(11):2407-15. doi: 10.1021/ar300327a. Epub 2013 Jul, 31. PMID:23902256 doi:http://dx.doi.org/10.1021/ar300327a
- ↑ doi: https://dx.doi.org/10.3390/antibiotics3020128#sthash.iyPihLj1.dpuf
- ↑ PMCID: PMC162717
- ↑ Patrick, G. (2005). Antibacterial Agents. An Introduction to Medicinal Chemistry (3rd Ed), pages 388-414.
- ↑ Neu, Harold. "The Crisis in Antibiotic Resistance." Science (1992) 257, 5073. ProQuest Medical Library: p. 1064-1072.
- ↑ Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010 Mar;54(3):969-76. doi: 10.1128/AAC.01009-09., Epub 2009 Dec 7. PMID:19995920 doi:http://dx.doi.org/10.1128/AAC.01009-09
- ↑ Leonard DA, Bonomo RA, Powers RA. Class D beta-lactamases: a reappraisal after five decades. Acc Chem Res. 2013 Nov 19;46(11):2407-15. doi: 10.1021/ar300327a. Epub 2013 Jul, 31. PMID:23902256 doi:http://dx.doi.org/10.1021/ar300327a
- ↑ Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother. 2000 Jun;44(6):1556-61. PMID:10817708


